| Product Code: ETC8111851 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malawi Oncology Companion Diagnostic Market Overview |
3.1 Malawi Country Macro Economic Indicators |
3.2 Malawi Oncology Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Malawi Oncology Companion Diagnostic Market - Industry Life Cycle |
3.4 Malawi Oncology Companion Diagnostic Market - Porter's Five Forces |
3.5 Malawi Oncology Companion Diagnostic Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.6 Malawi Oncology Companion Diagnostic Market Revenues & Volume Share, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
3.7 Malawi Oncology Companion Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Malawi Oncology Companion Diagnostic Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Malawi Oncology Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Malawi |
4.2.2 Growing awareness about the benefits of companion diagnostics in oncology treatment |
4.2.3 Government initiatives to improve healthcare infrastructure and access to advanced diagnostics |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities and diagnostic technologies in remote areas of Malawi |
4.3.2 High cost associated with companion diagnostic tests |
4.3.3 Lack of skilled healthcare professionals to interpret and utilize companion diagnostic results effectively |
5 Malawi Oncology Companion Diagnostic Market Trends |
6 Malawi Oncology Companion Diagnostic Market, By Types |
6.1 Malawi Oncology Companion Diagnostic Market, By Product & Service |
6.1.1 Overview and Analysis |
6.1.2 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Product & Service, 2021- 2031F |
6.1.3 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Product, 2021- 2031F |
6.1.4 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Service, 2021- 2031F |
6.2 Malawi Oncology Companion Diagnostic Market, By Technology(Revenue, USD Million, 2021-2031) |
6.2.1 Overview and Analysis |
6.2.2 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Polymerase chain reaction (PCR), 2021- 2031F |
6.2.3 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Next-generation sequencing (NGS), 2021- 2031F |
6.2.4 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry (IHC), 2021- 2031F |
6.2.5 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), 2021- 2031F |
6.2.6 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Other technologies, 2021- 2031F |
6.3 Malawi Oncology Companion Diagnostic Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.3.3 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Non-small cell lung cancer, 2021- 2031F |
6.3.4 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Colorectal cancer, 2021- 2031F |
6.3.5 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Leukemia, 2021- 2031F |
6.3.6 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.3.7 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.4 Malawi Oncology Companion Diagnostic Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Pathology/Diagnostic laboratory, 2021- 2031F |
6.4.4 Malawi Oncology Companion Diagnostic Market Revenues & Volume, By Academic medical center, 2021- 2031F |
7 Malawi Oncology Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Malawi Oncology Companion Diagnostic Market Export to Major Countries |
7.2 Malawi Oncology Companion Diagnostic Market Imports from Major Countries |
8 Malawi Oncology Companion Diagnostic Market Key Performance Indicators |
8.1 Percentage increase in the adoption of companion diagnostics in oncology treatment |
8.2 Number of partnerships between diagnostic companies and healthcare providers in Malawi |
8.3 Improvement in patient outcomes and survival rates attributed to the use of companion diagnostics |
9 Malawi Oncology Companion Diagnostic Market - Opportunity Assessment |
9.1 Malawi Oncology Companion Diagnostic Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
9.2 Malawi Oncology Companion Diagnostic Market Opportunity Assessment, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
9.3 Malawi Oncology Companion Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Malawi Oncology Companion Diagnostic Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Malawi Oncology Companion Diagnostic Market - Competitive Landscape |
10.1 Malawi Oncology Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Malawi Oncology Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here